Loading the company…
Loading the company…
Families: Decompression & minimally invasive spine, Cervical fusion & disc arthroplasty.
All companies · Product and company coverage
In the last ten years FDA made 12 decisions for Companion Spine France (510(k) clearances, De Novo grants, PMA approvals and supplements) under the product codes MedaRep maps to 2 procedure families, the most in 2018 (4). The latest was on 2026-05-22.
| Family | Decisions on record |
|---|---|
| Decompression & minimally invasive spine | 17 |
| Cervical fusion & disc arthroplasty | 8 |
| Date | Kind | Number | Device |
|---|---|---|---|
| 2026-05-22 | PMA | P110008-S015 | coflex® Interlaminar Technology · Postapproval Study Protocol |
| 2026-04-01 | PMA | P240043-S001 | DIAM Spinal Stabilization System · Labeling Change - Indications/instructions/shelf life/tradename |
| 2025-12-10 | PMA | P240043 | DIAM Spinal Stabilization System · Prosthesis, spinous process spacer/plate |
| 2021-03-31 | PMA | P110008-S013 | coflex Interlaminar Stabilization Device · Postapproval Study Protocol |
| 2020-08-05 | PMA | P110008-S012 | coflex® Interlaminar Technology · Labeling Change - Indications/instructions/shelf life/tradename |
Decisions under the product codes mapped to the procedure families; devices filed under other codes are not here. Applicants are rolled up to Companion Spine France.